ACTA1 and pulmonary fibrosis: Consistently, the relative expression level of the lung fibrosis marker, TGF-β and α-SMA was elevated in the CS/LPS group relative to NC group, but this change was reversed in animals treated with roflumilast or either dose of GJT (Figure 6(B)).